BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30598263)

  • 21. VI-16, a newly synthesized flavonoid, induces apoptosis through the mitochondrial pathway in human hepatoma cells.
    Lu N; Wei L; Gong D; Gao Y; Dai Q; Li Z; Guo Q
    Oncol Rep; 2012 Mar; 27(3):873-9. PubMed ID: 22179765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells.
    Sun JG; Chen CY; Luo KW; Yeung CL; Tsang TY; Huang ZZ; Wu P; Fung KP; Kwok TT; Liu FY
    Chemotherapy; 2011; 57(2):162-72. PubMed ID: 21454974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells.
    Li F; Wang T; Wang Z; Chen X; Liu R
    Mol Med Rep; 2017 Nov; 16(5):6094-6101. PubMed ID: 28849080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
    Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M
    Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
    Huang X; Ma J; Xu J; Su Q; Zhao J
    Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.
    Zhang Y; Dai J; Deng H; Wan H; Liu M; Wang J; Li S; Li X; Tang H
    Br J Cancer; 2015 Jan; 112(2):365-74. PubMed ID: 25422913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells.
    Liu B; Shi Y; Peng W; Zhang Q; Liu J; Chen N; Zhu R
    Mol Med Rep; 2016 Jul; 14(1):159-64. PubMed ID: 27176768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway.
    Yee SB; Choi HJ; Chung SW; Park DH; Sung B; Chung HY; Kim ND
    Int J Oncol; 2015 Aug; 47(2):747-54. PubMed ID: 26096942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta1/SMAD signaling pathway mediates p53-dependent apoptosis in hepatoma cell lines.
    Wang CL; Wan YL; Liu YC; Huang ZQ
    Chin Med Sci J; 2006 Mar; 21(1):33-5. PubMed ID: 16615282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
    Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
    Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells.
    Zhang L; Li Y; Qiao L; Zhao Y; Wei Y; Li Y
    Int J Oncol; 2015 Aug; 47(2):632-40. PubMed ID: 26035065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asiatic acid, a triterpene, induces apoptosis through intracellular Ca2+ release and enhanced expression of p53 in HepG2 human hepatoma cells.
    Lee YS; Jin DQ; Kwon EJ; Park SH; Lee ES; Jeong TC; Nam DH; Huh K; Kim JA
    Cancer Lett; 2002 Dec; 186(1):83-91. PubMed ID: 12183079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
    Sharma A; Bhat MK
    Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo.
    He XX; Zhang YN; Yan JW; Yan JJ; Wu Q; Song YH
    Tumour Biol; 2016 Jan; 37(1):807-15. PubMed ID: 26250460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells.
    Tian Z; Shen J; Moseman AP; Yang Q; Yang J; Xiao P; Wu E; Kohane IS
    Int J Cancer; 2008 Jan; 122(1):31-8. PubMed ID: 17847033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.
    Bai N; Zhang C; Liang N; Zhang Z; Chang A; Yin J; Li Z; Luo N; Tan X; Luo N; Luo Y; Xiang R; Li X; Reisfeld RA; Stupack D; Lv D; Liu C
    Cancer Biol Ther; 2013 Jun; 14(6):511-20. PubMed ID: 23760493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
    Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.